75
Participants
Start Date
February 28, 2005
Primary Completion Date
November 30, 2010
Study Completion Date
November 30, 2010
Divalproex-extended release (DVP-ER)
Divalproex ER will be given in 250 mg or 500 mg tablets. Dosing is once a day, every day, for the duration of study participation, either 12 or 26 weeks.
Lithium
Extended release lithium will be provided in 300 mg capsules. Participants will be dosed to a therapeutic blood level of lithium from 0.8 to 1.2 mcg/L.
Quetiapine
Quetiapine will be dosed to efficacy, provided in 50 mg, 100 mg, 200 mg, or 300 mg pills.
VA Palo Alto Health Care System, Palo Alto
National Institute of Mental Health (NIMH)
NIH
Palo Alto Veterans Institute for Research
OTHER